Shaylee Yount in Immunotherapy - Cancer and Beyond 700 Collaborate2Cure:Engineering Regulatory T Cells for the Treatment of Graft-Versus-Host Disease, Tom Yankee, PharmD, PhDNovember 10, 2016
Shaylee Yount in Immunotherapy - Cancer and Beyond 756 Collaborate2Cure: Kansas City One Health Day, Zika Virus, Stephen Higgs, PhDNovember 3, 2016 - Kansas City One Health Day
Shaylee Yount in Immunotherapy - Cancer and Beyond 7251 Collaborate2Cure: Howling at the Cancer Moonshot, Carolyn Henry DVM, MS, DACVIMNovember 3, 2016 - Kansas City One Health Day
Shaylee Yount in Immunotherapy - Cancer and Beyond 7161 Collaborate2Cure: Treating Cancer with Ex Vivo-Activated Cancer Neoantigen-Specific Effector T Cells, Tammie WahausNovember 3, 2016 - Kansas City One Health Day
Shaylee Yount in Immunotherapy - Cancer and Beyond 6661 Collaborate2Cure: Practical Considerations for Translation of CAR-T Cell Therapies to the Market, Sara Mary Hall October 27, 2016
Shaylee Yount in Immunotherapy - Cancer and Beyond 7531 Collaborate2Cure: inCVAX: An in situ Autologous Cancer Vaccine, Joseph Raker, PhDOctober 27, 2016
Sara Mary Hall in Immunotherapy - Cancer and Beyond 37517 Engineering T cells: moving beyond leukemiaEngineering T cells: moving beyond leukemia Air date: Wednesday, September 28, 2016, 3:00:00 PM Category: WALS - Wednesday Afternoon Lectures Runtime: 00:49:...
Shaylee Yount in Immunotherapy - Cancer and Beyond 827 Collaborate2Cure: Hyperthermia: More Than an Adjuvant to Cancer Therapies, Stefan Bossmann, PhDCollaborate2Cure: October 13, 2016
Shaylee Yount in Immunotherapy - Cancer and Beyond 714 Collaborate2Cure:Biomaterials for Cell Delivery in Animal Models, Gabriel Converse, PhDCollaborate2Cure: October 13, 2016